These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 32950105)

  • 1. TV-circRGPD6 Nanoparticle Suppresses Breast Cancer Stem Cell-Mediated Metastasis via the miR-26b/YAF2 Axis.
    Lin X; Chen W; Wei F; Xie X
    Mol Ther; 2021 Jan; 29(1):244-262. PubMed ID: 32950105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoparticle Delivery of miR-34a Eradicates Long-term-cultured Breast Cancer Stem Cells via Targeting C22ORF28 Directly.
    Lin X; Chen W; Wei F; Zhou BP; Hung MC; Xie X
    Theranostics; 2017; 7(19):4805-4824. PubMed ID: 29187905
    [No Abstract]   [Full Text] [Related]  

  • 3. Long non-coding RNA LUCAT1/miR-5582-3p/TCF7L2 axis regulates breast cancer stemness via Wnt/β-catenin pathway.
    Zheng A; Song X; Zhang L; Zhao L; Mao X; Wei M; Jin F
    J Exp Clin Cancer Res; 2019 Jul; 38(1):305. PubMed ID: 31300015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Essential role of miR-200c in regulating self-renewal of breast cancer stem cells and their counterparts of mammary epithelium.
    Feng ZM; Qiu J; Chen XW; Liao RX; Liao XY; Zhang LP; Chen X; Li Y; Chen ZT; Sun JG
    BMC Cancer; 2015 Sep; 15():645. PubMed ID: 26400441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroR-760 suppresses cancer stem cell subpopulation and breast cancer cell proliferation and metastasis: By down-regulating NANOG.
    Han ML; Wang F; Gu YT; Pei XH; Ge X; Guo GC; Li L; Duan X; Zhu MZ; Wang YM
    Biomed Pharmacother; 2016 May; 80():304-310. PubMed ID: 27133070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-7 reduces the BCSC subset by inhibiting XIST to modulate the miR-92b/Slug/ESA axis and inhibit tumor growth.
    Li M; Pan M; You C; Zhao F; Wu D; Guo M; Xu H; Shi F; Zheng D; Dou J
    Breast Cancer Res; 2020 Mar; 22(1):26. PubMed ID: 32143670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of breast cancer growth via miR-7 suppressing ALDH1A3 activity concomitant with decreasing breast cancer stem cell subpopulation.
    Pan M; Li M; You C; Zhao F; Guo M; Xu H; Li L; Wang L; Dou J
    J Cell Physiol; 2020 Feb; 235(2):1405-1416. PubMed ID: 31347176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448.
    Bamodu OA; Huang WC; Lee WH; Wu A; Wang LS; Hsiao M; Yeh CT; Chao TY
    BMC Cancer; 2016 Feb; 16():160. PubMed ID: 26917489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin mediates induction of miR-708 to inhibit self-renewal and chemoresistance of breast cancer stem cells through targeting CD47.
    Tan W; Tang H; Jiang X; Ye F; Huang L; Shi D; Li L; Huang X; Li L; Xie X; Xie X
    J Cell Mol Med; 2019 Sep; 23(9):5994-6004. PubMed ID: 31273952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-495 is upregulated by E12/E47 in breast cancer stem cells, and promotes oncogenesis and hypoxia resistance via downregulation of E-cadherin and REDD1.
    Hwang-Verslues WW; Chang PH; Wei PC; Yang CY; Huang CK; Kuo WH; Shew JY; Chang KJ; Lee EY; Lee WH
    Oncogene; 2011 May; 30(21):2463-74. PubMed ID: 21258409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-638 represses the stem cell characteristics of breast cancer cells by targeting E2F2.
    Lin QY; Wang JQ; Wu LL; Zheng WE; Chen PR
    Breast Cancer; 2020 Jan; 27(1):147-158. PubMed ID: 31410735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells.
    Shimono Y; Zabala M; Cho RW; Lobo N; Dalerba P; Qian D; Diehn M; Liu H; Panula SP; Chiao E; Dirbas FM; Somlo G; Pera RA; Lao K; Clarke MF
    Cell; 2009 Aug; 138(3):592-603. PubMed ID: 19665978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. microRNA-128-3p overexpression inhibits breast cancer stem cell characteristics through suppression of Wnt signalling pathway by down-regulating NEK2.
    Chen Y; Wu N; Liu L; Dong H; Liu X
    J Cell Mol Med; 2020 Jul; 24(13):7353-7369. PubMed ID: 32558224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monospecific antibody targeting of CDH11 inhibits epithelial-to-mesenchymal transition and represses cancer stem cell-like phenotype by up-regulating miR-335 in metastatic breast cancer, in vitro and in vivo.
    Chen JH; Huang WC; Bamodu OA; Chang PM; Chao TY; Huang TH
    BMC Cancer; 2019 Jun; 19(1):634. PubMed ID: 31248373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel lncRNA ROPM-mediated lipid metabolism governs breast cancer stem cell properties.
    Liu S; Sun Y; Hou Y; Yang L; Wan X; Qin Y; Liu Y; Wang R; Zhu P; Teng Y; Liu M
    J Hematol Oncol; 2021 Oct; 14(1):178. PubMed ID: 34715882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-7 suppresses brain metastasis of breast cancer stem-like cells by modulating KLF4.
    Okuda H; Xing F; Pandey PR; Sharma S; Watabe M; Pai SK; Mo YY; Iiizumi-Gairani M; Hirota S; Liu Y; Wu K; Pochampally R; Watabe K
    Cancer Res; 2013 Feb; 73(4):1434-44. PubMed ID: 23384942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNAs, a Promising Target for Breast Cancer Stem Cells.
    Das PK; Siddika MA; Asha SY; Aktar S; Rakib MA; Khanam JA; Pillai S; Islam F
    Mol Diagn Ther; 2020 Feb; 24(1):69-83. PubMed ID: 31758333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Value of a BCSC-associated MicroRNA Signature in Hormone Receptor-Positive HER2-Negative Breast Cancer.
    Gong C; Tan W; Chen K; You N; Zhu S; Liang G; Xie X; Li Q; Zeng Y; Ouyang N; Li Z; Zeng M; Zhuang S; Lau WY; Liu Q; Yin D; Wang X; Su F; Song E
    EBioMedicine; 2016 Sep; 11():199-209. PubMed ID: 27566954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of apoptosis inhibitor c-FLIP selectively eliminates breast cancer stem cell activity in response to the anti-cancer agent, TRAIL.
    Piggott L; Omidvar N; Martí Pérez S; French R; Eberl M; Clarkson RW
    Breast Cancer Res; 2011 Sep; 13(5):R88. PubMed ID: 21914219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hsa_circ_002178 Promotes the Growth and Migration of Breast Cancer Cells and Maintains Cancer Stem-like Cell Properties Through Regulating miR-1258/KDM7A Axis.
    Li W; Yang X; Shi C; Zhou Z
    Cell Transplant; 2020; 29():963689720960174. PubMed ID: 32951449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.